We appreciate the review of our recent article summarizing our process of prescribing diagnostic vascular unit laboratory testing in those with or suspected of having COVID-19 and algorithms for empirical anticoagulation. Porres-Aguilar and colleagues propose that a pulmonary embolism response team (PERT) may be ideally suited for assisting and managing the venous thrombotic complications in COVID-19-infected patients. The coagulopathy associated with COVID-19 is significant and characterized by elevated D-dimer and factor VIII as well as venous thrombosis, and pulmonary embolism and pulmonary artery thrombosis. They state that our recommended algorithms lack a strong evidence base, and we agree. The basis for our recommendations for obtaining diagnostic imaging is extrapolated from existing evidence-based guidelines, with the goal of allocating imaging to patients most likely to benefit in a resource-scare environment. Our recommendation for empirical heparin anticoagulation was largely based on prior experience with treating H1N1 infection, for which the pulmonary artery embolism or thrombosis rate was very high.[@bib1] Since our article came out, more data have accrued that heparin may be beneficial for these patients, including an observed mortality benefit among \>300 intensive care unit patients in New York City,[@bib2] in part because of direct antithrombotic but also antiviral binding effects.[@bib3] Of note, we are tracking very closely bleeding complications associated with our protocols, and so far, this seems very safe. We agree that the PERTs are multidisciplinary and are similar to our group. In fact, Dr Barnes is the head of the PERT group at Michigan. A major question not answered yet is whether invasive therapies for diagnosed pulmonary artery embolism or thrombosis would be of benefit in the COVID-19-infected patients.

Thus, in agreement with Porres-Aguilar and colleagues, some form of multidisciplinary team to help manage the COVID-19-related thrombotic diagnoses and treatment makes much sense and will help add to the experience in treating these extremely challenging patients.
